Detalhe da pesquisa
1.
GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med
; 387(13): 1196-1206, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36170501
2.
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape.
Nature
; 568(7750): 112-116, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30918399
3.
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
Mol Ther
; 31(3): 801-809, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36518078
4.
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Blood
; 138(7): 531-543, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33851211
5.
Therapeutic T cell engineering.
Nature
; 545(7655): 423-431, 2017 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28541315
6.
CAR T cells: Building on the CD19 paradigm.
Eur J Immunol
; 51(9): 2151-2163, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34196410
7.
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
N Engl J Med
; 378(5): 449-459, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29385376
8.
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 134(7): 626-635, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31262783
9.
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Blood
; 134(26): 2361-2368, 2019 12 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31650176
10.
Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector.
Mol Ther
; 26(6): 1447-1456, 2018 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29678657
11.
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy.
Mol Ther
; 26(8): 1896-1905, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29910179
12.
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.
Mol Ther
; 25(5): 1117-1124, 2017 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28456379
13.
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
Blood
; 126(5): 616-9, 2015 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-26089395
14.
Safe mobilization of CD34+ cells in adults with ß-thalassemia and validation of effective globin gene transfer for clinical investigation.
Blood
; 123(10): 1483-6, 2014 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24429337
15.
Hematopoietic stem cell engineering at a crossroads.
Blood
; 119(5): 1107-16, 2012 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-22096239
16.
CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.
Biochem Biophys Res Commun
; 438(1): 84-9, 2013 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-23872144
17.
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood
; 118(18): 4817-28, 2011 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-21849486
18.
Perspectives on Manufacturing of High-Quality Cell Therapies.
Mol Ther
; 25(5): 1067-1068, 2017 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28462818
19.
Showcasing Clinical Development and Production of Cellular Therapies.
Mol Ther
; 25(4): 827-828, 2017 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28341560
20.
Targeting tumours with genetically enhanced T lymphocytes.
Nat Rev Cancer
; 3(1): 35-45, 2003 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-12509765